[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f9T3m_jOhGzre3qVX5nH4YnwS8aSOxfjS8D3wN3ikULM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":39,"rows":46},"Swiss Paraplegic Research, Nottwil",[4],70,false,11,1,3208,2,63,[14,17,20,23,25,27,29,31],{"name":15,"count":16},"Spinal Cord Injury",21,{"name":18,"count":19},"Spinal Cord Injuries",18,{"name":21,"count":22},"Neurogenic Lower Urinary Tract Dysfunction",4,{"name":24,"count":11},"Athletes",{"name":26,"count":11},"Chronic Pain",{"name":28,"count":11},"Dietary Supplements",{"name":30,"count":11},"Physical Education and Training\u002FMethods",{"name":32,"count":11},"Spinal Cord Injuries (SCI)",[34],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06633588","Decolonization Efficacy of Polyhexanide vs. Mupirocin","2027-03-30","Polyhexanide",[40,41,42,43,44,45],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[47,73,91,117,142,167,194,220],{"intervention":38,"totalTrials":9,"cells":48},{"EARLY_PHASE1":49,"PHASE1":52,"PHASE2":54,"PHASE3":56,"PHASE4":58,"NA":71},{"trials":50,"activeCount":51},[],0,{"trials":53,"activeCount":51},[],{"trials":55,"activeCount":51},[],{"trials":57,"activeCount":51},[],{"trials":59,"activeCount":9,"soonestReadout":37},[60],{"nctId":35,"briefTitle":36,"status":61,"phases":62,"primaryCompletion":37,"completion":63,"start":64,"enrollment":65,"conditions":66,"interventions":69},"RECRUITING",[44],"2027-04-30","2025-05-01",24,[67,68],"Staphylococcus Aureus","Colonization, Asymptomatic",[38,70],"Mupirocin and Chlorhexidine",{"trials":72,"activeCount":51},[],{"intervention":70,"totalTrials":9,"cells":74},{"EARLY_PHASE1":75,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":89},{"trials":76,"activeCount":51},[],{"trials":78,"activeCount":51},[],{"trials":80,"activeCount":51},[],{"trials":82,"activeCount":51},[],{"trials":84,"activeCount":9,"soonestReadout":37},[85],{"nctId":35,"briefTitle":36,"status":61,"phases":86,"primaryCompletion":37,"completion":63,"start":64,"enrollment":65,"conditions":87,"interventions":88},[44],[67,68],[38,70],{"trials":90,"activeCount":51},[],{"intervention":92,"totalTrials":9,"cells":93},"Uro-Vaxom",{"EARLY_PHASE1":94,"PHASE1":96,"PHASE2":98,"PHASE3":100,"PHASE4":102,"NA":115},{"trials":95,"activeCount":51},[],{"trials":97,"activeCount":51},[],{"trials":99,"activeCount":51},[],{"trials":101,"activeCount":51},[],{"trials":103,"activeCount":51},[104],{"nctId":105,"briefTitle":106,"status":107,"phases":108,"primaryCompletion":109,"completion":110,"start":111,"enrollment":65,"conditions":112,"interventions":114},"NCT04049994","Immunomodulation Therapy for Urinary Tract Infections","COMPLETED",[44],"2023-09-04","2023-10-31","2020-06-01",[18,113],"Urinary Tract Infections",[92],{"trials":116,"activeCount":51},[],{"intervention":118,"totalTrials":9,"cells":119},"Rivaroxaban Oral",{"EARLY_PHASE1":120,"PHASE1":122,"PHASE2":124,"PHASE3":126,"PHASE4":128,"NA":140},{"trials":121,"activeCount":51},[],{"trials":123,"activeCount":51},[],{"trials":125,"activeCount":51},[],{"trials":127,"activeCount":51},[],{"trials":129,"activeCount":51},[130],{"nctId":131,"briefTitle":132,"status":133,"phases":134,"primaryCompletion":135,"completion":135,"start":136,"enrollment":51,"conditions":137,"interventions":139},"NCT02970773","Absorption of Rivaroxaban in Patients With Cervical Spinal Cord Injury","WITHDRAWN",[44],"2018-12-07","2017-12-04",[18,138],"Thromboembolism",[118],{"trials":141,"activeCount":51},[],{"intervention":143,"totalTrials":9,"cells":144},"Cholecalciferol",{"EARLY_PHASE1":145,"PHASE1":147,"PHASE2":149,"PHASE3":151,"PHASE4":163,"NA":165},{"trials":146,"activeCount":51},[],{"trials":148,"activeCount":51},[],{"trials":150,"activeCount":51},[],{"trials":152,"activeCount":51},[153],{"nctId":154,"briefTitle":155,"status":107,"phases":156,"primaryCompletion":157,"completion":157,"start":158,"enrollment":159,"conditions":160,"interventions":162},"NCT04652544","Vitamin D Supplementation in Individuals With a Chronic Spinal Cord Injury",[43],"2024-01-23","2021-05-19",50,[18,161],"Vitamin D Deficiency",[143],{"trials":164,"activeCount":51},[],{"trials":166,"activeCount":51},[],{"intervention":168,"totalTrials":9,"cells":169},"Injection of Onabotulinum toxin",{"EARLY_PHASE1":170,"PHASE1":172,"PHASE2":174,"PHASE3":176,"PHASE4":178,"NA":180},{"trials":171,"activeCount":51},[],{"trials":173,"activeCount":51},[],{"trials":175,"activeCount":51},[],{"trials":177,"activeCount":51},[],{"trials":179,"activeCount":51},[],{"trials":181,"activeCount":51},[182],{"nctId":183,"briefTitle":184,"status":107,"phases":185,"primaryCompletion":186,"completion":187,"start":188,"enrollment":189,"conditions":190,"interventions":193},"NCT03388086","Efficacy of Two Onabotulinum Toxin Doses",[],"2019-04-30","2019-07-31","2018-02-01",56,[191,192],"Neurogenic Bladder","Overactive Detrusor",[168],{"intervention":195,"totalTrials":9,"cells":196},"opiate with bolus",{"EARLY_PHASE1":197,"PHASE1":199,"PHASE2":201,"PHASE3":203,"PHASE4":205,"NA":207},{"trials":198,"activeCount":51},[],{"trials":200,"activeCount":51},[],{"trials":202,"activeCount":51},[],{"trials":204,"activeCount":51},[],{"trials":206,"activeCount":51},[],{"trials":208,"activeCount":51},[209],{"nctId":210,"briefTitle":211,"status":107,"phases":212,"primaryCompletion":213,"completion":214,"start":215,"enrollment":216,"conditions":217,"interventions":219},"NCT02197741","The Effect of an Additional Bolus Application in Patients With Intrathecal Opiate Administration - a Pilot Study",[],"2012-12","2014-07","2012-02",10,[218],"Chronic Pain Syndrome",[195],{"intervention":221,"totalTrials":9,"cells":222},"antimuscarinic treatment",{"EARLY_PHASE1":223,"PHASE1":225,"PHASE2":227,"PHASE3":229,"PHASE4":231,"NA":233},{"trials":224,"activeCount":51},[],{"trials":226,"activeCount":51},[],{"trials":228,"activeCount":51},[],{"trials":230,"activeCount":51},[],{"trials":232,"activeCount":51},[],{"trials":234,"activeCount":51},[235],{"nctId":236,"briefTitle":237,"status":107,"phases":238,"primaryCompletion":239,"completion":239,"start":240,"enrollment":241,"conditions":242,"interventions":244},"NCT01600404","Effects of Antimuscarinics on Cognition in Spinal Cord Injury",[],"2015-11","2011-12",32,[243,18],"Mild Cognitive Impairment",[221]]